Selinexor
| CAS No. | 1393477-72-9 |
|---|---|
| MDL No. | MFCD27987944 |
| MF | C17H11F6N7O |
| MW | 443.30 |
| InChI Key | DEVSOMFAQLZNKR-RJRFIUFISA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Selinexor is a triazole compound with a 1H-1,2,4-triazole core substituted at positions 1 and 3 by (1Z)-3-oxo-3-[2-(pyrazin-2-yl)hydrazinyl]prop-1-en-1-yl and 3,5-bis(trifluoromethyl)phenyl groups, respectively. It is a prescription medicine approved for treating adult patients with relapsed or refractory diffuse large B-cell lymphoma. It functions as an exportin 1 inhibitor, antineoplastic agent, anti-inflammatory agent, and apoptosis inducer. It belongs to the classes of (trifluoromethyl)benzenes, triazoles, pyrazines, enamides, and hydrazides.
| CAS No. | 1393477-72-9 |
|---|---|
| Product Name | Selinexor |
Biological Targets
XPO1
Associated Conditions
myelofibrosis·lymphoma·small cell lung carcinoma·ovarian carcinoma·prostate cancer·
* The information provided here is compiled from public sources and is for reference only.
